Citius Oncology, Inc. (CTOR) — Cash Flow Reinvestment Rate
Citius Oncology, Inc. (CTOR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $0.46 (capex $0.46 ) from operating cash flow of $900.29K. See Citius Oncology, Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Citius Oncology, Inc. Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Citius Oncology, Inc. across 1 annual periods. For the full cash flow conversion analysis, see Citius Oncology, Inc. (CTOR) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Citius Oncology, Inc. (2024–2024)
Year-by-year capital reinvestment analysis for Citius Oncology, Inc.. See CTOR financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 39.57x | $5.00 Million | $126.35K | $4.00 | — |